Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01091558 · ClinicalTrials.gov registry record
Study of Effects of L-Arginine in Colitis and Colon Cancer
A clinical trial, sponsored by Vanderbilt University Medical Center.
- Completed
- Registry status
- 204
- Enrollment target
NCT01091558: Completed study, sponsored by Vanderbilt University Medical Center.
NCT01091558 is a clinical trial that has completed, run by Vanderbilt University Medical Center. The registered enrollment target is 204 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01091558 has completed, sponsored by Vanderbilt University Medical Center.
- COMPLETED
- Registry status
- 204 participants
- Enrollment target
Study Summary
The purpose of this study is to look at the importance of L-Arginine in the digestive tract. L-Arginine is an amino acid and is important in making proteins within the cell. The evaluation of colon tissue, blood, urine, diet, health history, and symptoms will help us learn more about L-Arginine and ulcerative colitis. The investigators believe these studies will provide new insights into the treatment for Inflammatory Bowel Disease (ulcerative colitis) and nutritional needs. The investigators plan to enroll 200 participants in this study over the next two years.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 204 participants |
| Start Date | 2009-09 |
| Est. Completion | 2011-12 |
What the finished NCT01091558 record still lists
NCT01091558 is an observational study that tracks outcomes without assigning an intervention. The registered 204 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT01091558 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01091558 about?
NCT01091558 is a clinical study titled "Study of Effects of L-Arginine in Colitis and Colon Cancer". The purpose of this study is to look at the importance of L-Arginine in the digestive tract. L-Arginine is an amino acid and is important in making proteins within the cell. The evaluation of colon tissue, blood, urine, diet, health history, and symptoms will help us learn more about L-Arginine and...
What is the current status of trial NCT01091558?
This trial is currently completed. The enrollment target is 204 participants. The study started on 2009-09. Estimated completion is 2011-12.
Who is sponsoring clinical trial NCT01091558?
This trial is sponsored by Vanderbilt University Medical Center, which has 677 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03481010 · 204 participants · NA
Periacetabular Osteotomy With and Without Arthroscopic Management of Central Compartment Pathology
- NCT04249830 · 204 participants · NA
Stem Cell Transplant From Donors After Alpha Beta Cell Depletion in Children and Young Adults
- NCT04503395 · 204 participants · NA
ShOrt neCK AAA RAndomized Trial - ESAR and FEVAR: SOCRATES
- NCT04793776 · 204 participants · NA
Manage Emotions to Reduce Aggression (MERA)
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia